| Secondary |
| Asthma |
27.4% |
| Hypertension |
8.5% |
| Cough |
7.3% |
| Drug Use For Unknown Indication |
6.7% |
| Rhinitis Allergic |
5.8% |
| Oliguria |
4.6% |
| Pulmonary Congestion |
4.6% |
| Oedema |
4.3% |
| Oral Herpes |
4.3% |
| Nasopharyngitis |
3.7% |
| Rash |
3.7% |
| Diabetes Mellitus |
2.7% |
| Osteoarthritis |
2.4% |
| Rheumatoid Arthritis |
2.4% |
| Type 2 Diabetes Mellitus |
2.4% |
| Constipation |
2.1% |
| Breast Cancer Metastatic |
1.8% |
| Depression |
1.8% |
| Eczema |
1.8% |
| Gastric Ulcer |
1.5% |
|
| Pyrexia |
10.0% |
| Rhabdomyolysis |
10.0% |
| Allergic Granulomatous Angiitis |
6.7% |
| Interstitial Lung Disease |
6.7% |
| Loss Of Consciousness |
6.7% |
| Adrenal Insufficiency |
5.0% |
| Liver Disorder |
5.0% |
| Stevens-johnson Syndrome |
5.0% |
| Tooth Hypoplasia |
5.0% |
| Toxic Epidermal Necrolysis |
5.0% |
| Wound |
5.0% |
| Aggression |
3.3% |
| Asthma |
3.3% |
| Blood Creatine Phosphokinase Increased |
3.3% |
| Epilepsy |
3.3% |
| Muscular Weakness |
3.3% |
| Myocardial Ischaemia |
3.3% |
| Shunt Malfunction |
3.3% |
| Thrombocytopenia |
3.3% |
| Thrombocytopenic Purpura |
3.3% |
|
| Concomitant |
| Asthma |
30.8% |
| Product Used For Unknown Indication |
24.4% |
| Drug Use For Unknown Indication |
8.9% |
| Hypertension |
5.4% |
| Prophylaxis |
3.3% |
| Rheumatoid Arthritis |
2.6% |
| Bronchitis |
2.6% |
| Epilepsy |
2.2% |
| Juvenile Idiopathic Arthritis |
2.2% |
| Insomnia |
2.0% |
| Juvenile Arthritis |
1.8% |
| Pneumonia |
1.8% |
| Rhinitis Allergic |
1.7% |
| Gastritis |
1.7% |
| Diabetes Mellitus |
1.6% |
| Constipation |
1.5% |
| Chronic Obstructive Pulmonary Disease |
1.4% |
| Osteoporosis |
1.4% |
| Dermatitis Atopic |
1.3% |
| Influenza |
1.2% |
|
| Asthma |
21.5% |
| Vomiting |
8.7% |
| Pyrexia |
6.2% |
| Hepatic Function Abnormal |
5.4% |
| Hypoglycaemia |
5.4% |
| Pneumonia |
5.0% |
| Interstitial Lung Disease |
4.5% |
| White Blood Cell Count Decreased |
4.5% |
| Loss Of Consciousness |
4.1% |
| Renal Impairment |
4.1% |
| Rash |
3.7% |
| Visual Acuity Reduced |
3.7% |
| Death |
3.3% |
| Status Epilepticus |
3.3% |
| Convulsion |
2.9% |
| Delirium |
2.9% |
| Drug Ineffective |
2.9% |
| Tremor |
2.9% |
| Drug Eruption |
2.5% |
| Erythema Multiforme |
2.5% |
|
| Interacting |
| Angina Pectoris |
25.4% |
| Diabetes Mellitus |
14.3% |
| Upper Respiratory Tract Inflammation |
12.7% |
| Hypertension |
7.9% |
| Hyperlipidaemia |
6.3% |
| Osteoporosis |
6.3% |
| Pneumonia Mycoplasmal |
6.3% |
| Product Used For Unknown Indication |
6.3% |
| Upper Respiratory Tract Infection |
6.3% |
| Autoimmune Thyroiditis |
3.2% |
| Benign Prostatic Hyperplasia |
1.6% |
| Depression |
1.6% |
| Insomnia |
1.6% |
|
| Muscular Weakness |
25.0% |
| Upper Respiratory Tract Infection |
25.0% |
| Hypotension |
12.5% |
| Joint Swelling |
12.5% |
| Nausea |
12.5% |
| Rhabdomyolysis |
12.5% |
|
